Has Jason Schultz, MD received payments from drug or device companies?

Yes. Drug and device makers reported $3,282 in general payments to Jason Schultz, MD across 47 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jason Schultz, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jason Schultz, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jason Schultz, MD

Interventional Cardiology · Duluth, MNNPI 1235331604

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (58.3%), travel and lodging and education — rather than concentrated in one kind of arrangement. Medtronic accounts for 74.9% of it on its own, with 5 other manufacturers making up the rest. Reporting peaked in 2019 at $2,630 and has fallen 99.1% since, to $25 in 2024. That places this record below the midpoint for interventional cardiology clinicians in MN, where the typical reported total is $5,396.

$3,282in general payments, 2019–2025

Across 47 payments — averaging $69.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Medtronic$2K
Edwards Lifesciences$308
Abbott$288
Boston Scientific$167
Chiesi USA, Inc.$48
Regeneron Healthcare Solutions, Inc.$12

$44,608in research payments, 2019–2025

Across 45 payments — averaging $991.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Daiichi Sankyo Inc.$24K
Novartis$21K

What the payments were for

Travel & lodging$1,30940%
Food & beverage$1,91258%
Education$602%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Medtronic(2 entities)	27	$2,459
Edwards Lifesciences	7	$308
Abbott	2	$288
Boston Scientific	6	$167
Chiesi USA, Inc.	4	$48
Regeneron Healthcare Solutions, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

CoreValve Evolut$1,533
NAVITOR$228
Edwards SAPIEN 3 Transcatheter Heart Valve$148
COREVALVE EVOLUT R$135

How this compares

$3,282 in reported general payments places this provider in the 35th percentile of 84 interventional cardiology providers in Minnesota.

See all interventional cardiology providers in Minnesota →

Medicare billing

Part B allowed, 2024

$45,905

Medicare patients

407

Services billed

582

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	76	$66,255
XareltoRivaroxaban	43	$52,779
JardianceEmpagliflozin	13	$8,254
Repatha SyringeEvolocumab	11	$6,430
Ezetimibe	57	$1,744
Atorvastatin Calcium	75	$1,392
Torsemide	18	$1,289
Metoprolol Succinate	61	$1,148
ClopidogrelClopidogrel Bisulfate	74	$931
Isosorbide Mononitrate ErIsosorbide Mononitrate	27	$676
Rosuvastatin Calcium	40	$506
Diltiazem 24hr Er (Cd)Diltiazem Hcl	11	$338
Amlodipine Besylate	31	$328
Lisinopril	27	$317
Furosemide	59	$293

Paid to pharmacies, not to this prescriber.

Other interventional cardiology in Duluth

Leif ChristiansonDuluth$5K
Wilson GineteDuluth$4K
Kalkidan BishuDuluth$2K
Faraz Nasim KazmiDuluth$2K
Thom DahleSaint Cloud$1.1M
Stephen KiddSaint Cloud$607K
Brian StegmanSt Cloud$587K
Emmanouil BrilakisMinneapolis$548K
Wesley PedersenMinneapolis$493K
Michael ManolesMinneapolis$201K

See the full list for Minnesota →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →